Your browser doesn't support javascript.
loading
Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo, Danqi; Qu, Yuhua; Wang, Dao; Zhang, Benshan; Sun, Ming; Xiong, Hao; Lu, Jun; Yang, Rui; Zhao, Mingyi; Liu, Haiyan; Jiang, Hua.
Afiliación
  • Luo D; Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Qu Y; Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wang D; Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang B; Department of Hematology, Hunan Children's Hospital, Changsha, Hunan, China.
  • Sun M; Department of Hematology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiong H; Department of Hematology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu J; Department of Hematology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Yang R; Department of Pediatric Hematology, First People's Hospital of Chenzhou, Chenzhou, Hunan, China.
  • Zhao M; Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Liu H; Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Jiang H; Department of Hematology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
Front Immunol ; 15: 1384640, 2024.
Article en En | MEDLINE | ID: mdl-38720904
ABSTRACT

Background:

For children with severe aplastic anemia, if the first immunosuppressive therapy (IST) fails, it is not recommended to choose a second IST. Therefore, for patients without matched sibling donor (MSD) and matched unrelated donor (MUD), haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) can be chosen as a salvage treatment. This article aims to explore the comparison between upfront Haplo-HSCT and salvage Haplo-HSCT after IST.

Methods:

29 patients received salvage Haplo-HSCT, and 50 patients received upfront Haplo-HSCT. The two groups received Bu (Busulfan, 3.2mg/kg/d*2d on days -9 to-8), CY (Cyclophosphamide, 60mg/kg/d*2d on days -4 to-3), Flu (fludarabine, 40mg/m2/d*5d on days -9 to -5) and rabbit ATG (Anti-thymocyte globulin, total dose 10mg/kg divided into days -4 to -2).

Results:

The OS of the salvage Haplo-HSCT group showed no difference to the upfront Haplo-HSCT group (80.2 ± 8.0% vs. 88.7 ± 4.8%, p=0.37). The FFS of the salvage Haplo-HSCT group also showed no difference to the frontline Haplo-HSCT group (75 ± 8.2% vs. 84.9 ± 5.3%, p=0.27). There was no significant difference in the incidence of other complications after transplantation between the two groups, except for thrombotic microangiopathy (TMA). In the grouping analysis by graft source, the incidence of II-IV aGVHD in patients using PBSC ± BM+UCB was lower than that in the PBSC ± BM group (p=0.010).

Conclusion:

Upfront Haplo-HSCT and salvage Haplo-HSCT after IST in children with acquired severe aplastic anemia have similar survival outcomes. However, the risk of TMA increases after salvage Haplo-HSCT. This article provides some reference value for the treatment selection of patients. In addition, co-transplantation of umbilical cord blood may reduce the incidence of GVHD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Trasplante de Células Madre Hematopoyéticas / Trasplante Haploidéntico / Enfermedad Injerto contra Huésped / Anemia Aplásica Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Trasplante de Células Madre Hematopoyéticas / Trasplante Haploidéntico / Enfermedad Injerto contra Huésped / Anemia Aplásica Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: China